Platelet P2Y12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model. [electronic resource]
Producer: 20160317Description: 2562-70 p. digitalISSN:- 1524-4636
- Adenosine -- analogs & derivatives
- Anti-Inflammatory Agents -- therapeutic use
- Biomarkers -- blood
- Blood Platelets -- drug effects
- Chemotaxis, Leukocyte -- drug effects
- Clopidogrel
- Cytokines -- blood
- Endotoxins
- England
- Female
- Fibrin Fibrinogen Degradation Products -- metabolism
- Humans
- Inflammation -- blood
- Inflammation Mediators -- blood
- Male
- Platelet Adhesiveness -- drug effects
- Platelet Aggregation Inhibitors -- therapeutic use
- Prospective Studies
- Purinergic P2Y Receptor Antagonists -- therapeutic use
- Receptors, Purinergic P2Y12 -- blood
- Thrombosis -- blood
- Ticagrelor
- Ticlopidine -- analogs & derivatives
- Time Factors
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.